MoneyWorks4Me

A decent increase of about 39.08% in the sales to Rs. 4464.71 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 3210.12 millions during the year-ago period.The company almost doubled its revenue to Rs. 512.25 millions  from Rs. 248.15 millions in the quarter ended June 2026.Operating Profit saw a handsome growth to 1179.19 millions from 851.30 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4464.71 3210.12 39.08 4464.71 3210.12 39.08 14053.81 12995.89 8.14
Other Income 37.87 52.55 -27.94 37.87 52.55 -27.94 150.08 176.82 -15.12
PBIDT 1179.19 851.30 38.52 1179.19 851.30 38.52 2840.01 3869.57 -26.61
Interest 305.17 270.31 12.90 305.17 270.31 12.90 1205.76 1616.50 -25.41
PBDT 874.02 580.99 50.44 874.02 580.99 50.44 1580.05 1130.57 39.76
Depreciation 361.77 332.84 8.69 361.77 332.84 8.69 1367.95 1345.12 1.70
PBT 512.25 248.15 106.43 512.25 248.15 106.43 212.10 -214.55 -198.86
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -414.55 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -414.55 0.00
PAT 512.25 248.15 106.43 512.25 248.15 106.43 212.10 200.00 6.05
Equity 114.64 114.46 0.16 114.64 114.46 0.16 114.62 114.43 0.17
PBIDTM(%) 26.41 26.52 -0.41 26.41 26.52 -0.41 20.21 29.78 -32.13
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..